PMC:1064895 / 4337-4545 JSONTXT

Annnotations TAB JSON ListView MergeView

    test3

    {"project":"test3","denotations":[{"id":"T2213","span":{"begin":116,"end":121},"obj":"Protein"},{"id":"T2174","span":{"begin":116,"end":121},"obj":"Protein"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    BioNLP16_Messiy

    {"project":"BioNLP16_Messiy","denotations":[{"id":"T3733","span":{"begin":116,"end":121},"obj":"Protein"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    BioNLP16_DUT

    {"project":"BioNLP16_DUT","denotations":[{"id":"T4622","span":{"begin":116,"end":121},"obj":"Protein"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    2_test

    {"project":"2_test","denotations":[{"id":"15642134-9182915-4202015","span":{"begin":99,"end":100},"obj":"9182915"},{"id":"15642134-11669582-4202015","span":{"begin":99,"end":100},"obj":"11669582"},{"id":"15642134-11592370-4202015","span":{"begin":99,"end":100},"obj":"11592370"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    biosemtest

    {"project":"biosemtest","denotations":[{"id":"T2729","span":{"begin":122,"end":127},"obj":"UMLS/C1825592"},{"id":"T2695","span":{"begin":57,"end":70},"obj":"UMLS/C0007589"},{"id":"T2694","span":{"begin":166,"end":172},"obj":"UMLS/C1299351"},{"id":"T2658","span":{"begin":176,"end":184},"obj":"UMLS/C1705908"},{"id":"T2638","span":{"begin":166,"end":172},"obj":"UMLS/C0205250"},{"id":"T2596","span":{"begin":4,"end":16},"obj":"UMLS/C0028128"},{"id":"T2589","span":{"begin":176,"end":184},"obj":"UMLS/C1550655"},{"id":"T2578","span":{"begin":20,"end":32},"obj":"UMLS/C0225369"},{"id":"T2570","span":{"begin":166,"end":172},"obj":"UMLS/C1522410"},{"id":"T2567","span":{"begin":131,"end":146},"obj":"UMLS/C0039097"},{"id":"T2536","span":{"begin":38,"end":41},"obj":"UMLS/C2348947"},{"id":"T2481","span":{"begin":57,"end":70},"obj":"UMLS/C0205615"},{"id":"T2462","span":{"begin":75,"end":83},"obj":"UMLS/C1879547"},{"id":"T2452","span":{"begin":46,"end":53},"obj":"UMLS/C0085732"},{"id":"T2429","span":{"begin":88,"end":103},"obj":"UMLS/C0011306"},{"id":"T2406","span":{"begin":166,"end":172},"obj":"UMLS/C1561957"},{"id":"T2402","span":{"begin":166,"end":172},"obj":"UMLS/C1561958"},{"id":"T2392","span":{"begin":122,"end":127},"obj":"UMLS/C1522571"},{"id":"T2386","span":{"begin":176,"end":184},"obj":"UMLS/C0030705"},{"id":"T2368","span":{"begin":122,"end":127},"obj":"UMLS/C0384648"},{"id":"T2361","span":{"begin":176,"end":184},"obj":"UMLS/C1578479"},{"id":"T2355","span":{"begin":176,"end":184},"obj":"UMLS/C1578483"},{"id":"T2352","span":{"begin":176,"end":184},"obj":"UMLS/C1578480"},{"id":"T2349","span":{"begin":176,"end":184},"obj":"UMLS/C1578481"},{"id":"T2346","span":{"begin":176,"end":184},"obj":"UMLS/C1578486"},{"id":"T2342","span":{"begin":176,"end":184},"obj":"UMLS/C1578484"},{"id":"T2338","span":{"begin":176,"end":184},"obj":"UMLS/C1578485"},{"id":"T2309","span":{"begin":122,"end":127},"obj":"UMLS/C1623218"},{"id":"T2276","span":{"begin":54,"end":56},"obj":"UMLS/C0319022"},{"id":"T2512","span":{"begin":112,"end":118},"obj":"UMLS/C0456079"},{"id":"T2492","span":{"begin":112,"end":118},"obj":"UMLS/C0441889"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    pmc-enju-pas

    {"project":"pmc-enju-pas","denotations":[{"id":"T3276","span":{"begin":204,"end":208},"obj":"IN"},{"id":"T3275","span":{"begin":195,"end":203},"obj":"NN"},{"id":"T3274","span":{"begin":192,"end":194},"obj":"IN"},{"id":"T3273","span":{"begin":187,"end":191},"obj":"IN"},{"id":"T3272","span":{"begin":184,"end":186},"obj":"NN"},{"id":"T3271","span":{"begin":179,"end":183},"obj":"IN"},{"id":"T3270","span":{"begin":170,"end":178},"obj":"NN"},{"id":"T3269","span":{"begin":167,"end":169},"obj":"IN"},{"id":"T3258","span":{"begin":99,"end":103},"obj":"CD"},{"id":"T3257","span":{"begin":98,"end":99},"obj":"-LRB-"},{"id":"T3256","span":{"begin":92,"end":97},"obj":"NN"},{"id":"T3255","span":{"begin":82,"end":91},"obj":"JJ"},{"id":"T3254","span":{"begin":78,"end":81},"obj":"DT"},{"id":"T3253","span":{"begin":69,"end":77},"obj":"VB"},{"id":"T3252","span":{"begin":65,"end":68},"obj":"CC"},{"id":"T3251","span":{"begin":51,"end":64},"obj":"VB"},{"id":"T3250","span":{"begin":48,"end":50},"obj":"TO"},{"id":"T3249","span":{"begin":40,"end":47},"obj":"NN"},{"id":"T3248","span":{"begin":36,"end":39},"obj":"DT"},{"id":"T3247","span":{"begin":32,"end":35},"obj":"VB"},{"id":"T3246","span":{"begin":28,"end":31},"obj":"CC"},{"id":"T3245","span":{"begin":26,"end":27},"obj":"-COMMA-"},{"id":"T3244","span":{"begin":14,"end":26},"obj":"NN"},{"id":"T3243","span":{"begin":11,"end":13},"obj":"IN"},{"id":"T3242","span":{"begin":5,"end":10},"obj":"NN"},{"id":"T3268","span":{"begin":160,"end":166},"obj":"JJ"},{"id":"T3267","span":{"begin":146,"end":159},"obj":"RB"},{"id":"T3266","span":{"begin":141,"end":145},"obj":"VB"},{"id":"T3265","span":{"begin":134,"end":140},"obj":"NN"},{"id":"T3264","span":{"begin":125,"end":133},"obj":"JJ"},{"id":"T3263","span":{"begin":122,"end":124},"obj":"IN"},{"id":"T3262","span":{"begin":116,"end":121},"obj":"NN"},{"id":"T3261","span":{"begin":113,"end":115},"obj":"IN"},{"id":"T3260","span":{"begin":106,"end":112},"obj":"NN"},{"id":"T3259","span":{"begin":103,"end":104},"obj":"-RRB-"}],"relations":[{"id":"R1511","pred":"arg2Of","subj":"T3244","obj":"T3243"},{"id":"R1513","pred":"arg1Of","subj":"T3246","obj":"T3245"},{"id":"R1514","pred":"arg2Of","subj":"T3247","obj":"T3246"},{"id":"R1515","pred":"arg2Of","subj":"T3249","obj":"T3247"},{"id":"R1516","pred":"arg1Of","subj":"T3249","obj":"T3248"},{"id":"R1517","pred":"modOf","subj":"T3249","obj":"T3250"},{"id":"R1518","pred":"arg1Of","subj":"T3251","obj":"T3252"},{"id":"R1519","pred":"arg1Of","subj":"T3252","obj":"T3250"},{"id":"R1520","pred":"arg1Of","subj":"T3252","obj":"T3257"},{"id":"R1521","pred":"arg2Of","subj":"T3253","obj":"T3252"},{"id":"R1522","pred":"arg2Of","subj":"T3256","obj":"T3251"},{"id":"R1523","pred":"arg2Of","subj":"T3256","obj":"T3253"},{"id":"R1524","pred":"arg1Of","subj":"T3256","obj":"T3254"},{"id":"R1525","pred":"arg1Of","subj":"T3256","obj":"T3255"},{"id":"R1526","pred":"arg2Of","subj":"T3258","obj":"T3257"},{"id":"R1527","pred":"arg3Of","subj":"T3259","obj":"T3257"},{"id":"R1528","pred":"arg1Of","subj":"T3260","obj":"T3261"},{"id":"R1529","pred":"arg1Of","subj":"T3260","obj":"T3263"},{"id":"R1530","pred":"arg1Of","subj":"T3260","obj":"T3266"},{"id":"R1531","pred":"arg1Of","subj":"T3260","obj":"T3268"},{"id":"R1532","pred":"arg2Of","subj":"T3262","obj":"T3261"},{"id":"R1533","pred":"arg2Of","subj":"T3265","obj":"T3263"},{"id":"R1534","pred":"arg1Of","subj":"T3265","obj":"T3264"},{"id":"R1536","pred":"arg2Of","subj":"T3268","obj":"T3266"},{"id":"R1537","pred":"arg1Of","subj":"T3268","obj":"T3267"},{"id":"R1538","pred":"arg1Of","subj":"T3268","obj":"T3269"},{"id":"R1539","pred":"arg1Of","subj":"T3268","obj":"T3273"},{"id":"R1540","pred":"arg2Of","subj":"T3270","obj":"T3269"},{"id":"R1541","pred":"arg1Of","subj":"T3270","obj":"T3271"},{"id":"R1542","pred":"arg2Of","subj":"T3272","obj":"T3271"},{"id":"R1543","pred":"arg2Of","subj":"T3274","obj":"T3273"},{"id":"R1544","pred":"arg2Of","subj":"T3275","obj":"T3274"},{"id":"R1545","pred":"arg1Of","subj":"T3275","obj":"T3276"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    bionlp-st-ge-2016-coref

    {"project":"bionlp-st-ge-2016-coref","denotations":[{"id":"T3481","span":{"begin":116,"end":121},"obj":"Antecedent"}],"namespaces":[{"prefix":"_base","uri":"https://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    bionlp-st-ge-2016-test-proteins

    {"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T3502","span":{"begin":116,"end":121},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T3701","span":{"begin":116,"end":121},"obj":"http://www.uniprot.org/uniprot/Q16552"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    UBERON-AE

    {"project":"UBERON-AE","denotations":[{"id":"T2233","span":{"begin":125,"end":140},"obj":"http://purl.obolibrary.org/obo/UBERON_0001090"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T2791","span":{"begin":69,"end":97},"obj":"http://purl.obolibrary.org/obo/GO_0001773"},{"id":"T2790","span":{"begin":69,"end":97},"obj":"http://purl.obolibrary.org/obo/GO_0002270"},{"id":"T2789","span":{"begin":69,"end":97},"obj":"http://purl.obolibrary.org/obo/GO_0002266"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T3529","span":{"begin":116,"end":121},"obj":"http://purl.obolibrary.org/obo/GO_0030367"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T3560","span":{"begin":92,"end":97},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    simple1

    {"project":"simple1","denotations":[{"id":"T3673","span":{"begin":116,"end":121},"obj":"Protein"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    DLUT931

    {"project":"DLUT931","denotations":[{"id":"T3782","span":{"begin":116,"end":121},"obj":"Protein"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    bionlp-st-ge-2016-test-ihmc

    {"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T4497","span":{"begin":78,"end":104},"obj":"Entity"},{"id":"T4575","span":{"begin":14,"end":26},"obj":"Entity"},{"id":"T4554","span":{"begin":184,"end":186},"obj":"Protein"},{"id":"T4523","span":{"begin":116,"end":121},"obj":"Protein"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    bionlp-st-ge-2016-spacy-parsed

    {"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T4247","span":{"begin":204,"end":208},"obj":"IN"},{"id":"T4246","span":{"begin":195,"end":203},"obj":"NNS"},{"id":"T4245","span":{"begin":192,"end":194},"obj":"IN"},{"id":"T4244","span":{"begin":187,"end":191},"obj":"IN"},{"id":"T4243","span":{"begin":184,"end":186},"obj":"NNP"},{"id":"T4242","span":{"begin":179,"end":183},"obj":"IN"},{"id":"T4241","span":{"begin":170,"end":178},"obj":"NNS"},{"id":"T4240","span":{"begin":167,"end":169},"obj":"IN"},{"id":"T4239","span":{"begin":160,"end":166},"obj":"JJR"},{"id":"T4238","span":{"begin":146,"end":159},"obj":"RB"},{"id":"T4237","span":{"begin":141,"end":145},"obj":"VBD"},{"id":"T4236","span":{"begin":134,"end":140},"obj":"NNS"},{"id":"T4235","span":{"begin":125,"end":133},"obj":"JJ"},{"id":"T4234","span":{"begin":122,"end":124},"obj":"IN"},{"id":"T4233","span":{"begin":116,"end":121},"obj":"NNP"},{"id":"T4232","span":{"begin":113,"end":115},"obj":"IN"},{"id":"T4231","span":{"begin":106,"end":112},"obj":"NNS"},{"id":"T4230","span":{"begin":104,"end":105},"obj":"."},{"id":"T4229","span":{"begin":103,"end":104},"obj":"NNP"},{"id":"T4228","span":{"begin":99,"end":103},"obj":"CD"},{"id":"T4227","span":{"begin":98,"end":99},"obj":"NNP"},{"id":"T4226","span":{"begin":92,"end":97},"obj":"NNS"},{"id":"T4225","span":{"begin":82,"end":91},"obj":"JJ"},{"id":"T4224","span":{"begin":78,"end":81},"obj":"DT"},{"id":"T4223","span":{"begin":69,"end":77},"obj":"VB"},{"id":"T4222","span":{"begin":65,"end":68},"obj":"CC"},{"id":"T4221","span":{"begin":51,"end":64},"obj":"VB"},{"id":"T4220","span":{"begin":48,"end":50},"obj":"TO"},{"id":"T4219","span":{"begin":40,"end":47},"obj":"NN"},{"id":"T4218","span":{"begin":36,"end":39},"obj":"DT"},{"id":"T4217","span":{"begin":32,"end":35},"obj":"VBZ"},{"id":"T4216","span":{"begin":28,"end":31},"obj":"CC"},{"id":"T4215","span":{"begin":26,"end":27},"obj":","},{"id":"T4214","span":{"begin":14,"end":26},"obj":"NNS"},{"id":"T4213","span":{"begin":11,"end":13},"obj":"IN"},{"id":"T4212","span":{"begin":5,"end":10},"obj":"NN"}],"relations":[{"id":"R2125","pred":"acomp","subj":"T4239","obj":"T4237"},{"id":"R2134","pred":"prep","subj":"T4240","obj":"T4237"},{"id":"R2138","pred":"pobj","subj":"T4241","obj":"T4240"},{"id":"R2140","pred":"prep","subj":"T4242","obj":"T4241"},{"id":"R2145","pred":"pobj","subj":"T4243","obj":"T4242"},{"id":"R2149","pred":"prep","subj":"T4244","obj":"T4237"},{"id":"R2153","pred":"prep","subj":"T4245","obj":"T4244"},{"id":"R2157","pred":"pobj","subj":"T4246","obj":"T4245"},{"id":"R2161","pred":"prep","subj":"T4247","obj":"T4246"},{"id":"R2219","pred":"pobj","subj":"T4214","obj":"T4213"},{"id":"R2224","pred":"det","subj":"T4218","obj":"T4219"},{"id":"R2225","pred":"dobj","subj":"T4219","obj":"T4217"},{"id":"R2227","pred":"aux","subj":"T4220","obj":"T4221"},{"id":"R2228","pred":"acl","subj":"T4221","obj":"T4219"},{"id":"R2229","pred":"cc","subj":"T4222","obj":"T4221"},{"id":"R2231","pred":"conj","subj":"T4223","obj":"T4221"},{"id":"R2232","pred":"det","subj":"T4224","obj":"T4226"},{"id":"R2233","pred":"amod","subj":"T4225","obj":"T4226"},{"id":"R2234","pred":"dobj","subj":"T4226","obj":"T4223"},{"id":"R2235","pred":"compound","subj":"T4227","obj":"T4229"},{"id":"R2236","pred":"compound","subj":"T4228","obj":"T4229"},{"id":"R2238","pred":"appos","subj":"T4229","obj":"T4226"},{"id":"R2240","pred":"nsubj","subj":"T4231","obj":"T4237"},{"id":"R2242","pred":"prep","subj":"T4232","obj":"T4231"},{"id":"R2243","pred":"pobj","subj":"T4233","obj":"T4232"},{"id":"R2244","pred":"prep","subj":"T4234","obj":"T4231"},{"id":"R2246","pred":"amod","subj":"T4235","obj":"T4236"},{"id":"R2247","pred":"pobj","subj":"T4236","obj":"T4234"},{"id":"R2248","pred":"ROOT","subj":"T4237","obj":"T4237"},{"id":"R2250","pred":"advmod","subj":"T4238","obj":"T4239"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    bionlp-st-ge-2016-test-tees

    {"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T3639","span":{"begin":160,"end":166},"obj":"Positive_regulation"},{"id":"T3638","span":{"begin":106,"end":112},"obj":"Gene_expression"},{"id":"T3636","span":{"begin":116,"end":121},"obj":"Protein"}],"relations":[{"id":"R1771","pred":"themeOf","subj":"T3636","obj":"T3638"},{"id":"R1772","pred":"themeOf","subj":"T3638","obj":"T3639"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}

    testone

    {"project":"testone","denotations":[{"id":"T2127","span":{"begin":116,"end":121},"obj":"Protein"}],"text":"tric oxide by chondrocytes, and has the ability to differentiate and activate the dendritic cells [8-10]. Levels of IL-17 in synovial fluids were significantly higher in patients with RA than in patients with"}